CYTALUX™for the Intraoperative Imaging of Prostate Cancer

NCT06434909 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Cytalux™ (pafolacianine) for fluorescent imaging
PROCEDURE: Image Guided Surgery

Sponsor

Indiana University

Collaborators

[object Object]